173 related articles for article (PubMed ID: 17487351)
1. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?
Wuttig D; Kunze D; Fuessel S; Toma M; Stade J; Kotzsch M; Kappler M; Taubert H; Schwenzer B; Baretton G; Hakenberg OW; Meye A; Wirth MP
Int J Oncol; 2007 Jun; 30(6):1317-24. PubMed ID: 17487351
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
Atlasi Y; Mowla SJ; Ziaee SA
Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
He XF; Wen DG; Hou JQ; He J; Cen JN
Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC).
Ling X; Yang J; Tan D; Ramnath N; Younis T; Bundy BN; Slocum HK; Yang L; Zhou M; Li F
Lung Cancer; 2005 Sep; 49(3):353-61. PubMed ID: 15936846
[TBL] [Abstract][Full Text] [Related]
5. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA.
Fuessel S; Herrmann J; Ning S; Kotzsch M; Kraemer K; Schmidt U; Hakenberg OW; Wirth MP; Meye A
Cancer Lett; 2006 Feb; 232(2):243-54. PubMed ID: 16458121
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional expression of survivin and its splice variants in cervical carcinomas.
Futakuchi H; Ueda M; Kanda K; Fujino K; Yamaguchi H; Noda S
Int J Gynecol Cancer; 2007; 17(5):1092-8. PubMed ID: 17877643
[TBL] [Abstract][Full Text] [Related]
7. siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.
Ning S; Fuessel S; Kotzsch M; Kraemer K; Kappler M; Schmidt U; Taubert H; Wirth MP; Meye A
Int J Oncol; 2004 Oct; 25(4):1065-71. PubMed ID: 15375557
[TBL] [Abstract][Full Text] [Related]
8. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
9. Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
Ryan B; O'Donovan N; Browne B; O'Shea C; Crown J; Hill AD; McDermott E; O'Higgins N; Duffy MJ
Br J Cancer; 2005 Jan; 92(1):120-4. PubMed ID: 15611790
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Meng H; Lu C; Mabuchi H; Tanigawa N
Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of survivin splice isoforms in medulloblastomas.
Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
[TBL] [Abstract][Full Text] [Related]
12. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
13. The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions.
Kappler M; Rot S; Taubert H; Greither T; Bartel F; Dellas K; Hänsgen G; Trott KR; Bache M
Cancer Gene Ther; 2007 Dec; 14(12):994-1001. PubMed ID: 17885676
[TBL] [Abstract][Full Text] [Related]
14. Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation.
Kannangai R; Wang J; Liu QZ; Sahin F; Torbenson M
Int J Gastrointest Cancer; 2005; 35(1):53-60. PubMed ID: 15722574
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional expression of survivin and its splice variants in brain tumors in humans.
Yamada Y; Kuroiwa T; Nakagawa T; Kajimoto Y; Dohi T; Azuma H; Tsuji M; Kami K; Miyatake S
J Neurosurg; 2003 Oct; 99(4):738-45. PubMed ID: 14567610
[TBL] [Abstract][Full Text] [Related]
16. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
Hou JQ; He J; Wang XL; Wen DG; Chen ZX
Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
[TBL] [Abstract][Full Text] [Related]
17. [Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance].
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Bull Cancer; 2005 Mar; 92(3):219-26. PubMed ID: 15820916
[TBL] [Abstract][Full Text] [Related]
18. Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients.
Kappler M; Köhler T; Kampf C; Diestelkötter P; Würl P; Schmitz M; Bartel F; Lautenschläger C; Rieber EP; Schmidt H; Bache M; Taubert H; Meye A
Int J Cancer; 2001 Nov; 95(6):360-3. PubMed ID: 11668517
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
Taubert H; Kappler M; Bache M; Bartel F; Köhler T; Lautenschläger C; Blümke K; Würl P; Schmidt H; Meye A; Hauptmann S
Oncogene; 2005 Aug; 24(33):5258-61. PubMed ID: 15856009
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
Koike H; Sekine Y; Kamiya M; Nakazato H; Suzuki K
Urology; 2008 Dec; 72(6):1229-33. PubMed ID: 18336887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]